Actively Recruiting

Age: 18Years +
All Genders
NCT07215975

A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East

Led by Bristol-Myers Squibb · Updated on 2026-02-23

200

Participants Needed

2

Research Sites

268 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate luspatercept treatment in adults with transfusion-dependent beta-Thalassemia in the Middle East

CONDITIONS

Official Title

A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female participants of any race aged at least 18 years at time of initiation of luspatercept treatment
  • Participants with documented diagnosis of transfusion-dependent beta-thalassemia
  • Participants who have started luspatercept treatment as per the product's Summary of Product Characteristics no longer than 12 months before signing informed consent and are still on therapy
  • Participants whose decision to use luspatercept is separate from the decision to include them in this study
  • Participants who have signed informed consent for study participation and medical data collection
Not Eligible

You will not qualify if you...

  • Participants with contraindications to luspatercept as described in the latest locally approved Summary of Product Characteristics
  • Participants currently receiving or planned to receive any investigational drug, device, or intervention, or who have received any investigational product within 1 month or 5 half-lives before starting luspatercept
  • Participants who are currently pregnant, breastfeeding, or planning pregnancy during the study
  • Participants who have not signed informed consent for study participation and medical data collection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Sultan Qaboos University Hospital

Seeb, Muḩāfaz̧at Masqaţ, Oman, 123

Actively Recruiting

2

Prince Muhammad bin Nasser Hospital

Jizan, Saudi Arabia

Not Yet Recruiting

Loading map...

Research Team

B

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

CONTACT

F

First line of the email MUST contain NCT # and Site #.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here